The Association Between Inflammation and Colorectal Cancer

作者: Maria José Oliveira , Sérgia Velho

DOI: 10.1007/978-1-4614-8412-7_3

关键词:

摘要: Inflammation plays an important role in the development and progression of many forms cancer, including colorectal cancer (CRC). Several lines evidence support a major for inflammatory background CRC: (1) bowel disease patients have higher risk developing CRC; (2) regular use non-steroidal anti-inflammatory drugs (e.g., aspirin) prevents CRC cancer-free promotes regression established cancers; (3) even CRCs that do not develop under conditions are strongly infiltrated with multiple types pro-tumorigenic immune cells. In this chapter, association between chronic inflammation is reviewed molecular mechanisms leading to tumor summarized. addition, contributions distinct cell populations discussed. Finally, implications these associations prevention treatment highlighted.

参考文章(245)
Johnson Lin, Po-Wen Hsiao, Ted H. Chiu, Jui-I Chao, Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells. Biochemical Pharmacology. ,vol. 70, pp. 658- 667 ,(2005) , 10.1016/J.BCP.2005.05.028
Roopali Bansal Gupta, Noam Harpaz, Steven Itzkowitz, Sabera Hossain, Sierra Matula, Asher Kornbluth, Carol Bodian, Thomas Ullman, Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. ,vol. 133, pp. 1099- 1105 ,(2007) , 10.1053/J.GASTRO.2007.08.001
Steven H Itzkowitz, Asher Kornbluth, Elana Maser, Lloyd Mayer, Daniel H Present, David Sachar, Thomas Ullman, Yuki Young, None, Cancer in inflammatory bowel disease World Journal of Gastroenterology. ,vol. 14, pp. 378- 389 ,(2008) , 10.3748/WJG.14.378
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Jun Takeda, Kazuaki Kitajima, Shigehiko Fujii, Hideki Horiuchi, Hiroshige Hori, Yoko Chibana, Takashi Okuyama, Keiichi Tominaga, Kazuhito Ichikawa, Yuko Ono, Tadahisa Teramoto, Yasuo Ohkura, Joji Imura, Motoo Shinoda, Tsutomu Chiba, Choitsu Sakamoto, Hitoshi Kawamata, Takahiro Fujimori, Inhibitory effects of etodolac, a selective COX-2 inhibitor, on the occurrence of tumors in colitis-induced tumorigenesis model in rats. Oncology Reports. ,vol. 11, pp. 981- 985 ,(2004) , 10.3892/OR.11.5.981
TOSHIYUKI TAHARA, NAGAMU INOUE, TADAKAZU HISAMATSU, KAZUHIRO KASHIWAGI, HIROMASA TAKAISHI, TAKANORI KANAI, MAMORU WATANABE, HIROMASA ISHII, TOSHIFUMI HIBI, Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis Journal of Gastroenterology and Hepatology. ,vol. 20, pp. 710- 715 ,(2005) , 10.1111/J.1440-1746.2005.03803.X
Naoyuki Umetani, Shin Sasaki, Toshiaki Watanabe, Masaru Shinozaki, Keiji Matsuda, Hironori Ishigami, Eiji Ueda, Tetsuichiro Muto, Genetic Alterations in Ulcerative Colitis-associated Neoplasia Focusing on APC, K-ras Gene and Microsatellite Instability Japanese Journal of Cancer Research. ,vol. 90, pp. 1081- 1087 ,(1999) , 10.1111/J.1349-7006.1999.TB00681.X
Norihiko Takahashi, Takayuki Ohkuri, Shigenori Homma, Junya Ohtake, Daiko Wakita, Yuji Togashi, Hidemitsu Kitamura, Satoru Todo, Takashi Nishimura, First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer-hybrid epitope long peptide of MAGE-A4 cancer antigen Cancer Science. ,vol. 103, pp. 150- 153 ,(2012) , 10.1111/J.1349-7006.2011.02106.X
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young, Michael O. Blackstone, Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis Gastrointestinal Endoscopy. ,vol. 56, pp. 48- 54 ,(2002) , 10.1067/MGE.2002.125367